Subsequently, through batch MR, we screened immune cells affected by IL-2 and related inflammatory factors and preliminarily constructed an immunoregulatory network that promotes the progression of CH, with IL-2 as the starting point. The gene discussed is IL2; the disease is cyclic hematopoiesis.